Artículos del doctor: Dr Crispin Hiley Более 7589 artículos avalados por los mejores especialistas médicos

The MRIdian – an advanced MR linac

The MRIdian is a groundbreaking technology that combines high-resolution magnetic resonance imaging (MRI) with precise radiotherapy to treat tumours with exceptional accuracy. Known as magnetic resonance image-guided radiotherapy (MRIgRT), this method offers significant advantages over conventional radiotherapy by enabling real-time visualisation of tumours and their movement during treatment.

Stereotactic radiotherapy in the management of early-stage lung cancer

Stereotactic radiotherapy (SRT), also known as stereotactic body radiotherapy (SBRT), is an advanced form of radiation therapy that delivers highly focused beams of radiation to a specific target within the body. Leading consultant clinical oncologist Dr Crispin Hiley tells us all about how it’s used in the management of early-stage lung cancer.

Immunotherapy for lung cancer (Part 2): Consolidation therapy and metastatic lung cancer

Immunotherapy is a cancer treatment that uses medicines to stimulate your own immune system to detect and destroy cancer cells, helping to improve outcomes for people fighting lung cancer. Dr Crispin Hiley, highly renowned consultant clinical oncologist and Associate Professor, offers a comprehensive insight into consolidation therapy and the use of immunotherapy for lung cancer in the metastatic setting, in this conclusion of a two-part series of articles on immunotherapy for lung cancer.

Immunotherapy for lung cancer (Part 1): Neoadjuvant and adjuvant immunotherapy

Immunotherapy is a cancer treatment that uses medicines to stimulate your own immune system to detect and destroy cancer cells, helping to improve outcomes for people fighting lung cancer. In the first of a two-part series of articles on immunotherapy for lung cancer, Dr Crispin Hiley, highly renowned consultant clinical oncologist, offers an expert insight into neoadjuvant and adjuvant immunotherapy for lung cancer.

Early-stage lung cancer: Screening, diagnosis and treatment

Lung cancer is a common cause of death from cancer in the UK, affecting more than 47,000 people every year. While the long-term outlook improves every day from improvements in treatment of advanced disease, detection and treatment of cancer in its earliest stage(s) remains key for prognosis. Here, Dr Crispin Hiley, highly esteemed consultant clinical oncologist, provides a comprehensive overview of early-stage lung cancer.

показ результаты 7 7


Este sitio web utiliza Cookies propias y de terceros para recopilar información con la finalidad de mejorar nuestros servicios, para mostrarle publicidad relacionada con sus preferencias, así como analizar sus hábitos de navegación. El usuario tiene la posibilidad de configurar sus preferencias AQUI.